Literature DB >> 11113858

Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.

S Ramasami1, K M Kerr, A D Chapman, G King, J S Cockburn, R R Jeffrey.   

Abstract

Primary pulmonary adenocarcinoma was studied, looking for relationships between the expression of cell adhesion molecules (CAMs) E-cadherin, beta-catenin and CD44v6, and clinicopathological tumour parameters and patient post-operative survival. Formalin-fixed, paraffin-embedded tissue from 120 primary lung adenocarcinomas, including 23 poorly differentiated tumours, 17 of probable bronchial origin, and 29 with a prominent bronchioloalveolar pattern, together with nodal metastatic tumour from 34 of these patients was stained using monoclonal antibodies and immunohistochemistry. Sections were scored either high level (>10% cells positive) or low level (<10% positive). High level expression of CD44v6 was retained in 28.4% (34/120) of tumours, while high levels of E-cadherin (57.5%, 69/120) and beta-catenin (80. 8%, 97/120) were more frequent. For all CAMs, staining levels did not correlate with nodal status, stage or tumour type. The apical or basal staining seen in normal bronchial and alveolar epithelium was often seen in papillary, glandular, and bronchioloalveolar areas of tumour, while solid invasive tumour more often showed pericellular staining. When the staining for each CAM in 34 nodal metastases was compared with that in the corresponding primary tumour, a high degree of concordance was found, with no tendency for metastases to show less staining than the primary tumour. Expression of E-cadherin and beta-catenin in the primary tumour had no influence on post-operative survival, but patients whose tumours had low level CD44v6 expression had a poorer post-operative survival than those with high levels of CD44v6 (p=0.0014 for all patients, p=0.0012 for stage I patients only). In primary pulmonary adenocarcinoma, the levels of expression of E-cadherin, beta-catenin, and CD44v6 are not associated with lymph node metastases or tumour stage but the staining pattern is associated with tumour morphology. Low levels of CD44v6 expression predict a poor post-operative survival, independently of stage, while there is no such relationship with the expression of E-cadherin or beta-catenin. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113858     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH741>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.

Authors:  Junwei Chen; Tianhua Guo; Lei Zhang; Li-Xuan Qin; Samuel Singer; Robert G Maki; Takahiro Taguchi; Ronald Dematteo; Peter Besmer; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

Review 2.  Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors:  C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.

Authors:  Zhuang Luo; Rong-Rong Wu; Liang Lv; Peng Li; Li-Yan Zhang; Qing-Lin Hao; Wei Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma.

Authors:  Dongrong Situ; Hao Long; Peng Lin; Zhihua Zhu; Jiang Wang; Xu Zhang; Zeming Xie; Tiehua Rong
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-03       Impact factor: 4.553

6.  Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.

Authors:  Hao Jiang; Wei Zhao; Wei Shao
Journal:  Tumour Biol       Date:  2014-06-07

7.  Prognostic significance of CD44s expression in resected non-small cell lung cancer.

Authors:  Yoon Ho Ko; Hye Sung Won; Eun Kyoung Jeon; Sook Hee Hong; Sang Young Roh; Young Seon Hong; Jae Ho Byun; Chan-Kwon Jung; Jin Hyoung Kang
Journal:  BMC Cancer       Date:  2011-08-07       Impact factor: 4.430

8.  Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis.

Authors:  Yaosheng Liu; Haifeng Qing; Xiuyun Su; Cheng Wang; Zhou Li; Shubin Liu
Journal:  Med Sci Monit       Date:  2015-09-10

9.  Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study.

Authors:  Qian Wan; Dan Zhang; Qing Zhou; Ming Li; Yujuan Wang; Yang Song; Tianshu Xu
Journal:  Aging (Albany NY)       Date:  2019-11-03       Impact factor: 5.682

10.  Expression of calcium sensing receptor and E-cadherin correlated with survival of lung adenocarcinoma.

Authors:  Liyuan Wen; Lichun Sun; Yuhui Xi; Xuesong Chen; Ying Xing; Weiling Sun; Qingwei Meng; Li Cai
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.